Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373789 · ClinicalTrials.gov registry record · Phase 3
Refractory Urge Incontinence and Botox Injections
A Phase 3 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Terminated
- Registry status
- Phase 3
- Development phase
- 87
- Enrollment target
NCT00373789 is a Phase 3 study that was terminated before completion, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 87 participants.
The verdict
NCT00373789, a Phase 3 study, was terminated before completion, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to see whether Botox A (injected into the bladder muscle) can improve symptoms of urge incontinence that has not improved with usual medical treatments.
Interventions
- DRUG Botulinum Toxin A, bladder detrusor muscle injection
- DRUG Vehicle saline as placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373789
The ClinicalTrials.gov registry entry for NCT00373789 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botulinum Toxin A, bladder detrusor muscle injection is the first listed.
NCT00373789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00373789 about?
NCT00373789 is a clinical study titled "Refractory Urge Incontinence and Botox Injections". The purpose of this study is to see whether Botox A (injected into the bladder muscle) can improve symptoms of urge incontinence that has not improved with usual medical treatments.
What is the current status of trial NCT00373789?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 87 participants. The study started on 2006-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00373789?
The interventions under investigation include: Botulinum Toxin A, bladder detrusor muscle injection (DRUG), Vehicle saline as placebo (DRUG).
Who is sponsoring clinical trial NCT00373789?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.